Melatonin in experimental seizures and epilepsy.

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Melatonin, primarily used for sleep disorders, exhibits diverse physiological effects.
• Clinical data suggest potential benefits beyond insomnia, including adjunctive roles in various diseases.
• Melatonin modulates neuronal activity and acts as an antioxidant.

Purpose of the Study:

• To review the anticonvulsant and proconvulsant effects of melatonin.
• To evaluate the potential of melatonin as an adjunctive therapy for epilepsy.
• To assess the safety and efficacy of melatonin in human epilepsy treatment.

Main Methods:

• Review of experimental data on melatonin's effects on seizures.
• Analysis of clinical studies investigating melatonin in epilepsy.
• Assessment of reported adverse effects and toxicity.

Main Results:

• Vast experimental data support melatonin's anticonvulsant properties against various seizure types.
• Clinical evidence suggests melatonin may attenuate seizures, especially in juvenile intractable epilepsy, improving overall function.
• Some studies indicate potential proconvulsant effects or EEG abnormalities in specific epilepsy types, and high doses may cause side effects.

Conclusions:

• Melatonin demonstrates significant anticonvulsant properties in preclinical models.
• Its adjunctive use in epilepsy, particularly juvenile intractable epilepsy, shows promise with additional functional benefits.
• More rigorous clinical trials are necessary to establish melatonin's role in epilepsy management due to conflicting findings and potential side effects.